Exom Group
Exom Group is now Kapadi a leading global oncology CRO. Visit https://kapadi.com
Exom is a globally acting full-service CRO committed to the modernization of clinical trials by implementing innovative digital solutions. By combining our expertise in managing clinical trials with our proprietary, multi-modular, and cloud-based platform Genius SUITEโข, Exom improves efficiencies and escalates process speeds, while ensuring high-quality data and cost reduction, from early phase to
๐๐
๐ฐ๐ถ๐๐ถ๐ป๐ด ๐ก๐ฒ๐๐: ๐ข๐๐ฟ ๐ก๐ฒ๐ ๐ฃ๐ฟ๐ผ๐ณ๐ถ๐น๐ฒ ๐จ๐ป๐น๐ฒ๐ฎ๐๐ต๐ฒ๐ฑ!
๐๐ฆ๐ต ๐ณ๐ฆ๐ข๐ฅ๐บ ๐ง๐ฐ๐ณ ๐ข ๐ง๐ณ๐ฆ๐ด๐ฉ ๐ด๐ต๐ข๐ณ๐ต ๐ข๐ด ๐ธ๐ฆ ๐ต๐ณ๐ข๐ฏ๐ด๐ช๐ต๐ช๐ฐ๐ฏ ๐ฐ๐ถ๐ณ ๐ค๐ฐ๐ฎ๐ฑ๐ข๐ฏ๐บ ๐ฑ๐ณ๐ฐ๐ง๐ช๐ญ๐ฆ ๐ต๐ฐ ๐ข ๐ฏ๐ฆ๐ธ ๐ฉ๐ฐ๐ฎ๐ฆ, ๐ณ๐ฆ๐ง๐ญ๐ฆ๐ค๐ต๐ช๐ฏ๐จ ๐ต๐ฉ๐ฆ ๐ง๐ช๐ฏ๐ข๐ญ ๐ด๐ต๐ข๐จ๐ฆ๐ด ๐ฐ๐ง ๐ฐ๐ถ๐ณ ๐ฎ๐ฆ๐ณ๐จ๐ฆ๐ณ ๐ธ๐ฆ ๐ด๐ต๐ข๐ณ๐ต๐ฆ๐ฅ ๐ฃ๐ข๐ค๐ฌ ๐ช๐ฏ 2023. ๐๐ต๐ข๐บ ๐ต๐ถ๐ฏ๐ฆ๐ฅ ๐ง๐ฐ๐ณ ๐ต๐ฉ๐ฆ ๐ท๐ช๐ฃ๐ณ๐ข๐ฏ๐ต ๐ง๐ถ๐ต๐ถ๐ณ๐ฆ, ๐ฆ๐ฏ๐จ๐ข๐จ๐ช๐ฏ๐จ ๐ค๐ฐ๐ฏ๐ต๐ฆ๐ฏ๐ต ๐ข๐ฏ๐ฅ ๐ฆ๐น๐ค๐ช๐ต๐ช๐ฏ๐จ ๐ฏ๐ฆ๐ธ๐ด ๐ข๐ต ๐ต๐ฉ๐ฆ ๐ฏ๐ฆ๐ธ ๐ฑ๐ณ๐ฐ๐ง๐ช๐ญ๐ฆ ๐ฐ๐ง ๐๐ข๐ฑ๐ข๐ฅ๐ช!
Dear Valued Followers,
Get ready to witness the grand transformation as our beloved ๐๐
๐ผ๐บ ๐๐ฟ๐ผ๐๐ฝ profile locks its doors and triumphantly emerges on the vibrant new stage as ๐๐๐ฃ๐๐๐: ๐ง๐ต๐ฒ ๐ฃ๐ฟ๐ฒ๐บ๐ถ๐ฒ๐ฟ ๐ข๐ป๐ฐ๐ผ๐น๐ผ๐ด๐ ๐๐ฅ๐ข!
Under the banner of KAPADI, we proudly gather all our scattered profiles, uniting under a single, dynamic hub. Your precious subscriptions will seamlessly migrate to our new digital home, ensuring that you won't miss a beat of our engaging content.
We cherish the memories and connections forged on this platform and pledge to carry that same spirit forward into our new chapter. Stay tuned for even more insightful explorations, thought-provoking discussions, and valuable resources tailored to your needs!
Our doors may be closing on this old profile, but the conversation continues on our captivating new platform. Engage with us directly, share your thoughts, and let's paint a vibrant future together!
01/01/2024
Cheers to a new year filled with success, innovation, and opportunities! Hereโs wishing our esteemed clients, partners and colleagues a very happy and prosperous 2024. May this year bring you endless joy and numerous accomplishments. Looking forward to working with you in 2024.
As the year comes to a close, we find ourselves reflecting on the past twelve months, cherishing the valuable partnerships we've formed, and remembering all those unforgettable moments we've shared with our incredible team. As we usher in 2024, it is our hope that this season of joy brings you peace, prosperity, and even more reasons to smile. From everyone at Exom Group โ Here's wishing you a heartwarming Holiday Season and an inspiring start to 2024!
Counting down! Just 12 days until the American Society of Hematology annual meeting! We're eagerly looking forward to engaging with top-tier industry experts & showcasing our deep-rooted knowledge in hematology. Don't miss your chance to meet our specialist, Martha - she'll be there to answer your questions on hematology clinical trials. Excitement is in the blood!
Schedule your meeting at [email protected]
09/10/2023
Accelerating the future of clinical trials! Exom Group, in collaboration with AWS Partner Storm Reply, has automated remote patient consent with -powered chatbot technology. This digital revolution bypasses the need for in-person informed consent and boosts participation rates by allowing easy access through email and text.
Explore this life-saving innovation here: https://sqr.co/aws-vEngage/
20/03/2023
Together, we are working towards a brighter future for those living with inherited arrhythmogenic cardiomyopathy (ACM). With the support of the European Union and leading experts in preclinical research and cardiac genetics, we are proud to be part of the Geremy project โ a project seeking a genetic cure for ACM. Read more at https://swiy.co/EXG-GEREMY
Experience the difference with Exom Group. Our technology- and data-driven approach utilizes innovative technologies and advanced analytics to optimize clinical trial conduction. Get faster results, save money, and improve patient recruitment and retention with us. Learn more at www.exomgroup.com today!
It's the time of the year when you get ready for the holidays. The entire team at Exom Group sends warm winter wishes to all our valued customers. We hope this holiday season will bring you joy and happiness. Stay safe where ever you are. We look forward to a successful 2023.
The future of clinical trials is here with Genius vENGAGE.
Genius vENGAGE is the first โverbal consentโ for remote patient engagement in clinical trials. Learn more at www.exomgroup.com or contact us.
Clicca qui per richiedere la tua inserzione sponsorizzata.
Digitare
Contatta lo studio
Telefono
Sito Web
Indirizzo
Milan
20124